Exploring Novel Non-Operative Treatments for Osteoarthritis: An Examination of Innovative Therapies
DOI:
https://doi.org/10.12775/QS.2025.38.58169Keywords
cartilage regeneration, osteoarthritis, disease-modyfing osteoarthritis drugs, emerging therapies, pain management, cell-based therapies, regenerative medicineAbstract
Osteoarthritis (OA) is a prevalent degenerative joint disease that significantly impacts the quality of life of millions worldwide, particularly the elderly. While conventional non-surgical treatments, such as NSAIDs, intra-articular injections, and physical therapy, provide symptomatic relief, their long-term efficacy and safety remain limited. Recent advancements in understanding OA pathophysiology have spurred the development of innovative therapeutic strategies targeting disease progression. This review examines emerging pharmacological and regenerative approaches, including disease-modifying osteoarthritis drugs (DMOADs), biologics, and cell-based therapies. Cutting-edge technologies such as RNA interference, CRISPR/Cas9, and advanced regenerative medicine are also explored for their potential to revolutionize OA management. Additionally, the integration of novel therapies with traditional interventions is discussed, highlighting opportunities for a more personalized, multimodal approach to OA care. Despite significant progress, challenges such as translational hurdles, cost barriers, and long-term efficacy require further investigation. This review emphasizes the transformative potential of emerging therapies in addressing the unmet needs of OA patients and shaping future treatment paradigms.
References
1. Cao P, Li Y, Tang Y, Ding C, Hunter DJ. Pharmacotherapy for knee osteoarthritis: current and emerging therapies. Expert Opin Pharmacother 2020; 21;7:797–809. doi:10.1080/14656566.2020.1732924.
2. Wu Y, Goh EL, Wang D, Ma S. Novel treatments for osteoarthritis: a recent update. Open Access Rheumatol 2018; 10:135–140. doi:10.2147/OARRR.S176666.
3. Jiang P, Hu K, Jin L, Luo Z. A brief review of current treatment options for osteoarthritis including disease-modifying osteoarthritis drugs (DMOADs) and novel therapeutics. Annals of Medicine & Surgery 2024; 86;7:4042–4048. doi:10.1097/MS9.0000000000002214.
4. Liang J, Liu L, Feng H, Yue Y, Zhang Y, Wang Q, Zhao H. Therapeutics of osteoarthritis and pharmacological mechanisms: A focus on RANK/RANKL signaling. Biomedicine & Pharmacotherapy 2023; 167:115646. doi:10.1016/J.BIOPHA.2023.115646.
5. Clouet J, Vinatier C, Merceron C, Pot-vaucel M, Maugars Y, Weiss P, Grimandi G, Guicheux J. From osteoarthritis treatments to future regenerative therapies for cartilage. Drug Discov Today 2009; 14;19–20:913–925. doi:10.1016/J.DRUDIS.2009.07.012.
6. Tanikella AS, Hardy MJ, Frahs SM, Cormier AG, Gibbons KD, Fitzpatrick CK, Oxford JT. Emerging Gene-Editing Modalities for Osteoarthritis. International Journal of Molecular Sciences 2020, Vol. 21, Page 6046 2020; 21;17:6046. doi:10.3390/IJMS21176046.
7. Farinelli L, Riccio M, Gigante A, De Francesco F. Pain Management Strategies in Osteoarthritis. Biomedicines 2024, Vol. 12, Page 805 2024; 12;4:805. doi:10.3390/BIOMEDICINES12040805.
8. Ghouri A, Conaghan PG. Update on novel pharmacological therapies for osteoarthritis. https://doi.org/10.1177/1759720X19864492 2019; 11. doi:10.1177/1759720X19864492.
9. D’Arcy Y, Mantyh P, Yaksh T, Donevan S, Hall J, Sadrarhami M, Viktrup L. Treating osteoarthritis pain: mechanisms of action of acetaminophen, nonsteroidal anti-inflammatory drugs, opioids, and nerve growth factor antibodies. Postgrad Med 2021; 133;8:879–894. doi:10.1080/00325481.2021.1949199.
10. Steinmeyer J, Konttinen YT. Oral treatment options for degenerative joint disease—presence and future. Adv Drug Deliv Rev 2006; 58;2:168–211. doi:10.1016/J.ADDR.2006.01.007.
11. Berenbaum F. New horizons and perspectives in the treatment of osteoarthritis. Arthritis Res Ther 2008; 10;SUPPL. 2:1–7. doi:10.1186/AR2462/FIGURES/1.
12. Wong RSY. Disease-Modifying Effects of Long-Term and Continuous Use of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in Spondyloarthritis. Adv Pharmacol Pharm Sci 2019; 2019;1:5324170. doi:10.1155/2019/5324170.
13. Richette P, Latourte A, Frazier A. Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend? Expert Opin Drug Saf 2015; 14;8:1259–1268. doi:10.1517/14740338.2015.1056776.
14. Berthelot JM, Darrieutort-Lafitte C, Le Goff B, Maugars Y. Strong opioids for noncancer pain due to musculoskeletal diseases: Not more effective than acetaminophen or NSAIDs. Joint Bone Spine 2015; 82;6:397–401. doi:10.1016/J.JBSPIN.2015.08.003.
15. Esser S, Bailey A. Effects of exercise and physical activity on knee osteoarthritis. Curr Pain Headache Rep 2011; 15;6:423–430. doi:10.1007/S11916-011-0225-Z/TABLES/1.
16. Fitzgerald GK, Oatis C. Role of physical therapy in management of knee osteoarthritis. Curr Opin Rheumatol 2004; 16;2:143–147. doi:10.1097/00002281-200403000-00013.
17. Xiao C, Zhuang Y, Kang Y. Effects of Wu Qin xi Qigong exercise on physical functioning in elderly people with knee osteoarthritis: A randomized controlled trial. Geriatr Gerontol Int 2020; 20;10:899–903. doi:10.1111/GGI.14007.
18. Skou ST, Bricca A, Roos EM. The impact of physical activity level on the short- and long-term pain relief from supervised exercise therapy and education: a study of 12,796 Danish patients with knee osteoarthritis. Osteoarthritis Cartilage 2018; 26;11:1474–1478. doi:10.1016/J.JOCA.2018.07.010.
19. Frech TM, Clegg DO. The utility of nutraceuticals in the treatment of osteoarthritis. Curr Rheumatol Rep 2007; 9;1:25–30. doi:10.1007/S11926-007-0018-X/METRICS.
20. Castrogiovanni P, Trovato FM, Loreto C, Nsir H, Szychlinska MA, Musumeci G. Nutraceutical Supplements in the Management and Prevention of Osteoarthritis. International Journal of Molecular Sciences 2016, Vol. 17, Page 2042 2016; 17;12:2042. doi:10.3390/IJMS17122042.
21. Akhtar N, Haqqi TM. Current nutraceuticals in the management of osteoarthritis: A review. Ther Adv Musculoskelet Dis 2012; 4;3:181–207. doi:10.1177/1759720X11436238/ASSET/IMAGES/LARGE/10.1177_1759720X11436238-FIG1.JPEG.
22. Goiato MC, da Silva EVF, de Medeiros RA, Túrcio KHL, dos Santos DM. Are intra-articular injections of hyaluronic acid effective for the treatment of temporomandibular disorders? A systematic review. Int J Oral Maxillofac Surg 2016; 45;12:1531–1537. doi:10.1016/J.IJOM.2016.06.004.
23. Trellu S, Dadoun S, Berenbaum F, Fautrel B, Gossec L. Intra-articular injections in thumb osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. Joint Bone Spine 2015; 82;5:315–319. doi:10.1016/J.JBSPIN.2015.02.002.
24. Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H. Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthritis Cartilage 2006; 14;2:163–170. doi:10.1016/J.JOCA.2005.09.007.
25. Guermazi A, Hunter DJ, Kloppenburg M. Debate: Intra-articular steroid injections for osteoarthritis – harmful or helpful? Osteoarthritis Imaging 2023; 3;3:100163. doi:10.1016/J.OSTIMA.2023.100163.
26. Zhang W, Robertson WB, Zhao J, Chen W, Xu J. Emerging trend in the pharmacotherapy of osteoarthritis. Front Endocrinol (Lausanne) 2019; 10;JUL:428650. doi:10.3389/FENDO.2019.00431/BIBTEX.
27. Fanelli D, Weller G, Liu H. New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations. Neurology International 2021, Vol. 13, Pages 497-509 2021; 13;4:497–509. doi:10.3390/NEUROLINT13040049.
28. Jia E, Bartlett MG, Michael Bartlett CG. Recent advances in liquid chromatographic methods for the determination of selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors. Biomedical Chromatography 2020; 34;3:e4760. doi:10.1002/BMC.4760.
29. Jotanovic Z, Mihelic R, Sestan B, Dembic Z. Role of interleukin-1 inhibitors in osteoarthritis: An evidence-based review. Drugs Aging 2012; 29;5:343–358. doi:10.2165/11599350-000000000-00000/FIGURES/TAB3.
30. Cai X, Yuan S, Zeng Y, Wang C, Yu N, Ding C. New Trends in Pharmacological Treatments for Osteoarthritis. Front Pharmacol 2021; 12:645842. doi:10.3389/FPHAR.2021.645842/BIBTEX.
31. Miller RE, Block JA, Malfait AM. Nerve growth factor blockade for the management of osteoarthritis pain: What can we learn from clinical trials and preclinical models? Curr Opin Rheumatol 2017; 29;1:110–118. doi:10.1097/BOR.0000000000000354.
32. Oo WM, Hunter DJ. Nerve Growth Factor (NGF) Inhibitors and Related Agents for Chronic Musculoskeletal Pain: A Comprehensive Review. BioDrugs 2021 35:6 2021; 35;6:611–641. doi:10.1007/S40259-021-00504-8.
33. Eibl JK, Strasser BC, Ross GM. Structural, biological, and pharmacological strategies for the inhibition of nerve growth factor. Neurochem Int 2012; 61;8:1266–1275. doi:10.1016/J.NEUINT.2012.10.008.
34. Paik J, Duggan ST, Keam SJ. Triamcinolone Acetonide Extended-Release: A Review in Osteoarthritis Pain of the Knee. Drugs 2019; 79;4:455–462. doi:10.1007/S40265-019-01083-3/TABLES/3.
35. Langworthy MJ, Conaghan PG, Ruane JJ, Kivitz AJ, Lufkin J, Cinar A, Kelley SD. Efficacy of Triamcinolone Acetonide Extended-Release in Participants with Unilateral Knee Osteoarthritis: A Post Hoc Analysis. Adv Ther 2019; 36;6:1398–1411. doi:10.1007/S12325-019-00944-3/TABLES/3.
36. Cho Y, Jeong S, Kim H, Kang D, Lee J, Kang SB, Kim JH. Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions. Experimental & Molecular Medicine 2021 53:11 2021; 53;11:1689–1696. doi:10.1038/s12276-021-00710-y.
37. Vincent TL. Of mice and men: converging on a common molecular understanding of osteoarthritis. Lancet Rheumatol 2020; 2;10:e633–e645. doi:10.1016/S2665-9913(20)30279-4.
38. Diekman BO, Guilak F. Stem cell-based therapies for osteoarthritis: Challenges and opportunities. Curr Opin Rheumatol 2013; 25;1:119–126. doi:10.1097/BOR.0B013E32835AA28D.
39. Tevlin R, desJardins-Park H, Huber J, DiIorio SE, Longaker MT, Wan DC. Musculoskeletal tissue engineering: Adipose derived stromal cell implementation for the treatment of osteoarthritis. Biomaterials 2022; 286:121544. doi:10.1016/J.BIOMATERIALS.2022.121544.
40. Kennedy O, Kitson A, Okpara C, Chow LW, Gonzalez-Fernandez T. Immunomodulatory Strategies for Cartilage Regeneration in Osteoarthritis. Tissue Eng Part A 2024; 30;7–8:259–271. doi:10.1089/TEN.TEA.2023.0255.
41. Taylor J, Woodcock S. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way? SLAS Discovery 2015; 20;8:1040–1051. doi:10.1177/1087057115590069.
42. Unniyampurath U, Pilankatta R, Krishnan MN. RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi? International Journal of Molecular Sciences 2016, Vol. 17, Page 291 2016; 17;3:291. doi:10.3390/IJMS17030291.
43. Kampmann M, Horlbeck MA, Chen Y, Tsai JC, Bassik MC, Gilbert LA, Villalta JE, Kwon SC, Chang H, Kim VN, Weissman JS. Next-generation libraries for robust RNA interference-based genome-wide screens. Proc Natl Acad Sci U S A 2015; 112;26:E3384–E3391. doi:10.1073/PNAS.1508821112/SUPPL_FILE/PNAS.201508821SI.PDF.
44. Caine DJ, Golightly YM. Osteoarthritis as an outcome of paediatric sport: an epidemiological perspective. Br J Sports Med 2011; 45;4:298–303. doi:10.1136/BJSM.2010.081984.
45. Mugele H, Plummer A, Steffen K, Stoll J, Mayer F, Müller J. General versus sports-specific injury prevention programs in athletes: A systematic review on the effect on injury rates. PLoS One 2018; 13;10:e0205635. doi:10.1371/JOURNAL.PONE.0205635.
46. Lequesne MG, Dang N, Lane NE. Sport practice and osteoarthritis of the limbs. Osteoarthritis Cartilage 1997; 5;2:75–86. doi:10.1016/S1063-4584(97)80001-5.
47. Carbone A, Rodeo S. Review of current understanding of post-traumatic osteoarthritis resulting from sports injuries. Journal of Orthopaedic Research 2017; 35;3:397–405. doi:10.1002/JOR.23341.
48. Whittaker JL, Roos EM. A pragmatic approach to prevent post-traumatic osteoarthritis after sport or exercise-related joint injury. Best Pract Res Clin Rheumatol 2019; 33;1:158–171. doi:10.1016/J.BERH.2019.02.008.
49. Vannini F, Spalding T, Andriolo L, Berruto M, Denti M, Espregueira-Mendes J, Menetrey J, Peretti GM, Seil R, Filardo G. Sport and early osteoarthritis: the role of sport in aetiology, progression and treatment of knee osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy 2016; 24;6:1786–1796. doi:10.1007/S00167-016-4090-5/TABLES/1.
50. Carter CW, Micheli LJ. Training the child athlete: physical fitness, health and injury. Br J Sports Med 2011; 45;11:880–885. doi:10.1136/BJSPORTS-2011-090201.
51. Vad V, Hong HM, Zazzali M, Agi N, Basrai D. Exercise recommendations in athletes with early osteoarthritis of the knee. Sports Medicine 2002; 32;11:729–739. doi:10.2165/00007256-200232110-00004/FIGURES/9.
52. Brown DJ, Fletcher D. Effects of Psychological and Psychosocial Interventions on Sport Performance: A Meta-Analysis. Sports Medicine 2017; 47;1:77–99. doi:10.1007/S40279-016-0552-7/FIGURES/8.
53. Sappington R, Longshore K. Systematically Reviewing the Efficacy of Mindfulness-Based Interventions for Enhanced Athletic Performance. J Clin Sport Psychol 2015; 9;3:232–262. doi:10.1123/JCSP.2014-0017.
54. Schenk M, Miltenberger R. A review of behavioral interventions to enhance sports performance. Behavioral Interventions 2019; 34;2:248–279. doi:10.1002/BIN.1659.
55. Fogarty AE, Chiang MC, Douglas S, Yaeger LH, Ambrosio F, Lattermann C, Jacobs C, Borg-Stein J, Tenforde AS. Posttraumatic osteoarthritis after athletic knee injury: A narrative review of diagnostic imaging strategies. PM&R 2025; 17;1:96–106. doi:10.1002/PMRJ.13217.
56. Mohamad T, Jyotsna F, Farooq U et al. Individualizing Medicinal Therapy Post Heart Stent Implantation: Tailoring for Patient Factors. Cureus 2023; 15;8. doi:10.7759/CUREUS.43977.
57. Schumann M, Doherty C. Bridging Gaps in Wearable Technology for Exercise and Health professionals: A brief review. Int J Sports Med 2024; 45;13:949–957. doi:10.1055/A-2376-6332/ID/RIJSM-03-2024-10524-0008/BIB.
58. Yu SP, Hunter DJ. Intra-articular therapies for osteoarthritis. Expert Opin Pharmacother 2016; 17;15:2057–2071. doi:10.1080/14656566.2016.1232396.
59. Latourte A, Kloppenburg M, Richette P. Emerging pharmaceutical therapies for osteoarthritis. Nature Reviews Rheumatology 2020 16:12 2020; 16;12:673–688. doi:10.1038/s41584-020-00518-6.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Piotr Robert Bakuła, Kamila Jałocha, Joanna Zygadło
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 43
Number of citations: 0
